Stocks Hitting 52-Week Lows

Caladrius Biosciences Inc CLBS shares reached a new 52-week low of $0.72 after the company reported that it will discontinue an ongoing Phase 3 study of CLBS20 as monotherapy for metastatic melanoma. Anadarko Petroleum Corporation APC shares dropped 5.25 percent to touch a new 52-week low of $41.47. Deutsche Bank downgraded Anadarko Petroleum from Buy to Hold and lowered the price target to $60.00. Alexza Pharmaceuticals, Inc. ALXA shares touched a new 52-week low of $0.521. Alexza Pharmaceuticals shares have dropped 65.68 percent over the past 52 weeks, while the S&P 500 index has declined 3.49 percent in the same period. Genesee & Wyoming Inc GWR shares fell 4.88 percent to touch a new 52-week low of $49.47. RBC Capital downgraded Genesee & Wyoming from Outperform to Sector Perform and lowered the price target from $66 to $55.